Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 1992Journal of Clinical Oncology

Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.

View Full Paper
Ask AI
Bookmark
Share

Authors

JSJack W. SingerRutgers, The State University of New JerseyCBCD BucknerUniversity of IowaRCR CliftUniversity of Tennessee at Knoxville

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Singer et al. (1992) studied this question.

synapsesocial.com/papers/6a1dc69e79ea62caf6601a48https://doi.org/10.1200/jco.1992.10.9.1492
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Marrow transplantation for malignant plasma cell disorders: Summary of the Seattle experience*1989 · 40 citations
  2. 2Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study [see comments]1990 · 147 citations
  3. 3Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy.1991 · 51 citations
  4. 4Prognostic variables and clinical staging in multiple myeloma1989 · 48 citations
  5. 5Marrow Transplantation for the Treatment of Chronic Myelogenous Leukemia1986 · 555 citations